Navigation Links
deCODE Launches Phase II Clinical Testing of DG051 for the Prevention of Heart Attack
Date:10/9/2007

REYKJAVIK, Iceland, Oct. 9 /PRNewswire-FirstCall/ -- deCODE genetics (Nasdaq: DCGN) today announced that it has begun enrolling patients for its Phase IIa clinical trial for DG051, the company's leukotriene A4 hydrolase inhibitor being developed for the prevention of heart attack.

In Phase I studies completed earlier this year, DG051 significantly reduced the production of leukotriene B4 (LTB4) in a dose dependent manner. LTB4 is a pro-inflammatory molecule that deCODE's gene discovery and functional biology work identified as a key factor in modulating risk of heart attack. The Phase I studies showed DG051 to be safe and well-tolerated at all dose levels tested, with a favourable pharmacokinetic profile. DG051 was also recently evaluated in a 28-day Phase I study that further demonstrated that the drug can deliver significant, sustained reductions in LTB4 levels with once-daily dosing.

The design of the Phase IIa study is based upon these findings by studying the effect of DG051 in patients with a history of heart attack or coronary artery disease. The Phase IIa is a randomized, double-blind, placebo- controlled trial that will examine the impact of DG051 on the production of LTB4 as well as the compound's pharmacokinetic and safety and tolerability profiles in heart patients. The company will use the results from this study to inform dose selection for a larger Phase IIb trial planned to commence early next year.

"We are advancing DG051 as a novel means of preventing heart attack, the leading cause of death in the industrialized world. Our clinical studies thus far have shown that it effectively reins in the activity of a branch of the leukotriene pathway that has been linked to risk of heart attac
'/>"/>

SOURCE deCODE genetics
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Positive Clinical Results for DG041 Lead Product Development Highlights at deCODE R&D Event
2. deCODE Announces Positive Topline Results for Phase I Study of DG051 for the Prevention of Heart Attack
3. Data Available From Erbitux Phase III Study in First-Line Treatment of Advanced Lung Cancer
4. Phase 3 Results for Dabigatran Etexilate, an Investigational Oral Anticoagulant, Presented Today at the XXIst Congress of the International Society on Thrombosis and Haemostasis
5. YM BioSciences Announces Secondary Efficacy and Safety Findings in Randomized Phase IIB Aerolef Trial
6. Portola Pharmaceuticals Announces Positive Data from a Phase II Study of its Factor Xa Inhibitor at the XXI Congress of the International Society on Thrombosis and Haemostasis
7. Manhattan Pharmaceuticals Announces Results of Phase 2a Studies for Oral Oleoyl-estrone
8. Actemra (tocilizumab) Third Phase III Study Results Show Significant Improvement in Symptoms of Patients with Rheumatoid Arthritis
9. AVI BioPharma Partner Cook Medical Announces Completion of Patient Enrollment for APPRAISAL Phase II Clinical Trial for Treatment of Cardiovascular Disease
10. NexMed Announces Completion of Patient Enrollment in Two Pivotal Phase 3 Studies for Anti-Fungal Product
11. AM-Pharma Announces Positive Results of Phase IIa Clinical Trial with Alkaline Phosphatase For Ulcerative Colitis
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/19/2014)... , September 19, 2014 ... by Equipment (Cryotherapy, Heat, therapy, Hydrotherapy), Accessories (Posture Mirror, ... (Hospitals), Advanced technologies - Global Forecast to 2019" ... poised to reach $19,786.3 Million by 2019 from ... 6.8% from 2014 to 2019. Browse ...
(Date:9/19/2014)...  4WEB Medical announces the formal launch of the ... implants on the market today at this weekend,s ... Chicago .  The Osteotomy Truss System is ... with 74 size options included in one versatile set. ... 15 to 18 implant sizes, which limited a surgeon,s ...
(Date:9/19/2014)... STATION, N.J. , Sept. 19, 2014 Merck (NYSE: ... United States and Canada , is ... Desafiando La Diabetes: Logra Tus Metas , an educational program ... their blood sugar -- a key treatment goal to help reduce ... United States are at a higher risk for developing ...
Breaking Medicine Technology:Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 2Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 3Physiotherapy Equipment Market Worth $19,786.3 Million by 2019 44WEB Medical Unveils 3D-Printed Osteotomy Truss System 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 2Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 3Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 4Celebrity Chef Leticia Moreinos Schwartz Partners with Merck on Desafiando La Diabetes: Logra Tus Metas to Urge Hispanics With Type 2 Diabetes to Get to Their A1C Goal 5
... Aug. 13 Mylan Inc. (Nasdaq: www.mylan.com . ... This press release includes statements that constitute "forward-looking statements." ... provisions of the Private Securities Litigation Reform Act of ... actual future results may differ materially from those expressed ...
... VIEW, Calif. , Aug. 6 Alexza Pharmaceuticals, Inc. (Nasdaq: ... Chief Financial Officer, August J. Moretti will present during the Bank ... on Friday, August 13, 2010 at 10:40 am ET . ... York . , , , ...
Cached Medicine Technology:Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference 2Alexza Pharmaceuticals to Present at Bank of America Merrill Lynch 2010 Specialty Pharmaceuticals Conference 3
(Date:9/20/2014)... 20, 2014 Ticket Down is ... tickets for her 2015 “Honeymoon Tour.” This well-known ticket ... added savings. , In early 2015, fans will have a ... world across North America. Twenty-one-year-old Ariana Grande will hit the ... take her to 25 cities across the United States and ...
(Date:9/20/2014)... the popular online supplier of wedding dresses and special ... collection of cocktail gowns. This afternoon, the company announced ... outfits; it intends to expand its online market in ... cocktail dresses in the company’s online store. ... experience in the industry of women’s special occasion dresses. ...
(Date:9/20/2014)... Traditionally dentists have advised their patients against drinking ... is re-visiting that advice and changing his stance after ... wine have on oral health. “There’s good news and great ... be beneficial in protecting against gum disease, and red wine ... coffee was from the September 2014 issue of Boston ...
(Date:9/20/2014)... CA (PRWEB) September 20, 2014 ... of 3.1 out of 5, indicating a moderately favorable ... IBISWorld, this score reflects current and future pricing trends ... historically high prices. Other factors that negatively affect buyer ... demand for construction and the moderate switching costs. Buyers ...
(Date:9/20/2014)... 2014 RBSEO Services, which has occupied ... has announced it provides an affordable website SEO (Search ... This announcement would benefit those new and old businesses ... cannot afford to pay a big amount for their ... their websites in top search results for their business ...
Breaking Medicine News(10 mins):Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 2Health News:Ariana Grande Tickets in New York, Philadelphia, Orlando, Fairfax, Worcester, Toronto, Uncasville, Detroit, Miami, Pittsburgh, Cleveland, and Atlanta On Sale Today 3Health News:Fashionable Cocktail Dresses Unveiled Online at iFitDress.com 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 2Health News:South Charlotte Dentist, Dr. James Wells, is Changing His Advice on Coffee and Wine Drinking 3Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 2Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 3Health News:Plumbing Construction Services Procurement Category Market Research Report from IBISWorld Has Been Updated 4Health News:RBSEO Services Announces Affordable Website SEO Service at Only $175 2
... report encouraging news. The Cystinosis Research Foundation has ... which is designed to provide updates on cystinosis ... the 12 cystinosis grants issued in 2008. Cystinosis ... that afflicts about 2,000 children worldwide. The CRF ...
... that challenges the mandatory retirement of air traffic controllers at ... that air traffic controllers up to age 64 perform as ... The study of Canadian air traffic controllers, who can work ... Journal of Experimental Psychology . , The researchers found that ...
... because of the genetic BRCA mutations are more likely to ... their risk for the disease, compared to other women who ... of Texas ,M. D. Anderson Cancer Center. , The study, ... also finds that the emotional worry was a strong factor ...
... makeover transform the Riojas home, Mary Ann,s story of triumph over disability ... Hospital Central California. , ... Madera, CA (PRWEB) March 8, 2009 -- ... news that would change their lives forever - "Extreme Makeover: Home ...
... Messaging Solutions for Significant Savings, Fluid Integration and Streamlined ... ... Norcross, GA (PRWEB) March 8, 2009 -- EasyLink Services ... provider of comprehensive messaging services, including email fax ...
... disorder causes the other, study notes , , FRIDAY, ... the risk of depression, instead of the other way ... has identified a link between alcohol abuse or dependence ... one disorder causes the other, or whether a common ...
Cached Medicine News:Health News:2009 Science Report on Genetic Disease Released by Cystinosis Research Foundation 2Health News:2009 Science Report on Genetic Disease Released by Cystinosis Research Foundation 3Health News:Older air traffic controllers perform as well as young on job-related tasks 2Health News:Women with BRCA mutation, or worry, most likely to undergo prophylactic mastectomy 2Health News:Women with BRCA mutation, or worry, most likely to undergo prophylactic mastectomy 3Health News:Women with BRCA mutation, or worry, most likely to undergo prophylactic mastectomy 4Health News:Children's Hospital Central California and CVS/Pharmacy Wheelchair Fund Featured in "Extreme Makeover: Home Edition" 2Health News:Children's Hospital Central California and CVS/Pharmacy Wheelchair Fund Featured in "Extreme Makeover: Home Edition" 3Health News:Children's Hospital Central California and CVS/Pharmacy Wheelchair Fund Featured in "Extreme Makeover: Home Edition" 4Health News:Children's Hospital Central California and CVS/Pharmacy Wheelchair Fund Featured in "Extreme Makeover: Home Edition" 5Health News:Email Fax Provider, EasyLink Services, Announces Prominent Bio-Pharma Signing 2Health News:Email Fax Provider, EasyLink Services, Announces Prominent Bio-Pharma Signing 3Health News:Drinking May Trigger Genetic Marker for Depression 2
Blood sedimentation rate analysis...
... CA-7000 provides speed and precision in ... with Sysmex technology. With its ... of up to 300 samples or ... testing. This high performance, fully ...
... is our top-of-the-line device. The ... of the Qwik-Let® Elite, in ... feature. The Lan-X technology allows ... in the removal and disposal ...
... variable volume Finnpipette Techpette combines ... high performance pipette. Advanced pipetting ... range, ensures quality, safety, comfort ... the volume range is an ...
Medicine Products: